Interleukin-34 is a cytokine that promotes the differentiation and viability of monocytes and macrophages through the colony-stimulating factor-1 receptor (CSF1R\; MIM 164770) (Lin et al., 2008 [PubMed 18467591]).[supplied by OMIM, May 2008].
Chang, Lee, Song, Jang, Park, Hong, Ko, Kim, Kim, Lee, Heo: "IL-34 is associated with obesity, chronic inflammation, and insulin resistance." in: The Journal of clinical endocrinology and metabolism, Vol. 99, Issue 7, pp. E1263-71, (2014) (PubMed).
Li, Jin, Wu, Zhang, Hu, Cao, Chen: "Increased serum interleukin-34 in patients with coronary artery disease." in: The Journal of international medical research, Vol. 40, Issue 5, pp. 1866-70, (2012) (PubMed).
Mizuno, Doi, Mizoguchi, Jin, Noda, Sonobe, Takeuchi, Suzumura: "Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-? neurotoxicity." in: The American journal of pathology, Vol. 179, Issue 4, pp. 2016-27, (2011) (PubMed).
Oliveri, Cammarata, Augello, Mancuso, Tropea, Ajello, Padhye: "Rhizopus arrhizus in Italy as the causative agent of primary cerebral zygomycosis in a drug addict." in: European journal of epidemiology, Vol. 4, Issue 3, pp. 284-8, (1988) (PubMed).